BIO4

Serbia Targets Greater Role in Southeast Europe’s Clinical Research Market

Serbia could develop a larger role in Southeast Europe’s clinical-trials market by combining its medical institutions, specialist expertise, patient population and BIO4 ecosystem with competitive research costs. Clinical research has several characteristics that align with capabilities already present in the country, including university hospitals, specialist physicians, a sizeable population and lower operating costs than Western Europe. The sector also fits into Serbia’s expanding life-sciences policy agenda and could generate export revenues through specialised research services. Unlike commodity industries and low-cost…